Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Cost-Effectiveness of Initial vs Delayed Lanreotide for Treatment of Metastatic Enteropancreatic Neuroendocrine Tumors in the United States Barnes, J. I., Lin, J., Owens, D. K., Goldhaber-Fiebert, J., Kunz, P. L. LIPPINCOTT WILLIAMS & WILKINS. 2019: 429
View details for Web of Science ID 000462541800031